Molecular Aspects of Microcystin-induced Hepatotoxicity and Hepatocarcinogenesis

It is known that microcystin (MC) is a cyanotoxin that is a potent environmental inhibitor of eucariotic protein serine/threonine phosphatase 1 and 2A, both in vitro and in vivo. Consequently, these cyanobacterial toxins (MC–IARC group 2B carcinogen, MC extracts–group 3) are potent tumor promoters and there is an indication that they may also act as tumor initiators. The ability of microcystin-LR (MC-LR) to act as a tumor initiator is based on fact that it can induce DNA damage either by direct interaction with DNA or by indirect mechanisms through formation of reactive oxygen species (ROS). Both acute and chronic exposures, to either low or high doses of MC-LR, can activate apoptotic pathways. Chronic exposure to low concentrations of MC-LR contributes to increased risk for cancer development. Epidemiological studies, in certain areas of China, have suggested that MC is one of the risk factors for the high incidence of primary liver cancer (PLC). Recently, we have reported a correlation between PLC and cyanobacterial “blooms” in reservoirs used as a source for drinking water supply in central Serbia. It appears that the combination of acute and chronic exposures to both high and low doses of MC can lead to PLC initiation and promotion. Based on this, we propose that the requirement for the co-factors such as aflatoxin B1 and other mycotoxins, HBV, HCV, alcohol, etc. is not needed for initiation and promotion of PLC by MC-LR as was suggested earlier. The possible mechanisms of the genotoxicity of MC and its role as a hepatocarcinogen are outlined in this review. Furthermore, we show that the exposure of hepatocytes to MC can lead either to malignant proliferation or apoptosis.

[1]  A. Rebollo,et al.  Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. , 2003, Biochimie.

[2]  D. Dietrich,et al.  Guidance values for microcystins in water and cyanobacterial supplement products (blue-green algal supplements): a reasonable or misguided approach? , 2005, Toxicology and applied pharmacology.

[3]  M. Sheetz,et al.  Microtubule-dependent vesicle transport: modulation of channel and transporter activity in liver and kidney. , 1998, Physiological reviews.

[4]  C. Riccardi,et al.  Sphingolipids and the immune system. , 2003, Pharmacological research.

[5]  Masaharu Komatsu,et al.  Involvement of mitogen-activated protein kinase signaling pathways in microcystin-LR-induced apoptosis after its selective uptake mediated by OATP1B1 and OATP1B3. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  D. Barford,et al.  Co-crystallization of the catalytic subunit of the serine/threonine specific protein phosphatase 1 from human in complex with microcystin LR. , 1994, Journal of molecular biology.

[7]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[8]  B. Debuire,et al.  Mechanisms of hepatocarcinogenesis , 2011 .

[9]  S. Hooser,et al.  Fulminant Hepatocyte Apoptosis In Vivo Following Microcystin-LR Administration to Rats , 2000, Toxicologic pathology.

[10]  Qiying Lin,et al.  The expression of p53 and p16 in the course of microcystin-LR inducing of liver tumor , 2008 .

[11]  L. Moroder,et al.  Molecular structure of the cyanobacterial tumor‐promoting microcystins , 1994, FEBS letters.

[12]  B. Sykes,et al.  A Molecular Basis for Different Interactions of Marine Toxins with Protein Phosphatase-1 , 1997, The Journal of Biological Chemistry.

[13]  M. Filipič,et al.  Different sensitivities of human colon adenocarcinoma (CaCo-2), astrocytoma (IPDDC-A2) and lymphoblastoid (NCNC) cell lines to microcystin-LR induced reactive oxygen species and DNA damage. , 2008, Toxicon : official journal of the International Society on Toxinology.

[14]  G. Milczarek,et al.  Okadaic acid mediates p53 hyperphosphorylation and growth arrest in cells with wild-type p53 but increases aberrant mitoses in cells with non-functional p53. , 1999, Carcinogenesis.

[15]  W. Caselmann,et al.  Carcinogenesis of primary liver malignancies , 2000, Langenbeck's Archives of Surgery.

[16]  V. Baltic,et al.  Freshwater Cyanobacterial Blooms and Primary Liver Cancer Epidemiological Studies in Serbia , 2009, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[17]  J. Zwiller,et al.  Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases. , 1990, The Journal of biological chemistry.

[18]  Kati Laakso,et al.  Recurrent adenylation domain replacement in the microcystin synthetase gene cluster , 2007, BMC Evolutionary Biology.

[19]  Paul Greengard,et al.  Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1 , 1995, Nature.

[20]  T. Downing,et al.  An investigation into the detoxification of microcystin-LR by the glutathione pathway in Balb/c mice. , 2004, The international journal of biochemistry & cell biology.

[21]  D. Šuput,et al.  Microcystin-LR induces alterations in heart muscle. , 2006, Folia biologica.

[22]  J. Little,et al.  Requirement of wild‐type p53 protein for maintenance of chromosomal integrity , 2000, Molecular carcinogenesis.

[23]  M. Gehringer Microcystin‐LR and okadaic acid‐induced cellular effects: a dualistic response , 2004, FEBS letters.

[24]  H. Xia,et al.  Induction of apoptosis in human liver carcinoma HepG2 cell line by 5-allyl-7-gen-difluoromethylenechrysin. , 2009, World journal of gastroenterology.

[25]  Lirong Song,et al.  Responses of antioxidant systems in the hepatocytes of common carp (Cyprinus carpio L.) to the toxicity of microcystin-LR. , 2003, Toxicon : official journal of the International Society on Toxinology.

[26]  B. Hemmings,et al.  Serine/threonine protein phosphatases. , 1995, The Biochemical journal.

[27]  W. Carmichael,et al.  The repair of gamma-radiation-induced DNA damage is inhibited by microcystin-LR, the PP1 and PP2A phosphatase inhibitor. , 2006, Mutagenesis.

[28]  G. A. Miura,et al.  Tissue distribution, excretion and hepatic biotransformation of microcystin-LR in mice. , 1991, The Journal of pharmacology and experimental therapeutics.

[29]  D R Dietrich,et al.  Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. , 2005, Toxicology and applied pharmacology.

[30]  M. Yanagida,et al.  Phosphorylation of dis2 protein phosphatase at the C‐terminal cdc2 consensus and its potential role in cell cycle regulation. , 1994, The EMBO journal.

[31]  C. Ong,et al.  Genotoxicity of microcystic cyanobacteria extract of a water source in China. , 1999, Mutation research.

[32]  Xiaosong Hu,et al.  Ceramide induces apoptosis via a peroxisome proliferator-activated receptor γ-dependent pathway , 2006, Apoptosis.

[33]  Wei Yang,et al.  Induction of Apoptosis in Mouse Liver by Microcystin-LR , 2005, Molecular & Cellular Proteomics.

[34]  E. J. Moore,et al.  Microcystins (cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse colon. , 2000, Journal of toxicology and environmental health. Part A.

[35]  I. Falconer,et al.  Cytoskeletal changes in hepatocytes induced by Microcystis toxins and their relation to hyperphosphorylation of cell proteins. , 1992, Chemico-biological interactions.

[36]  Y. Ueno,et al.  Detection and identification of metabolites of microcystins formed in vivo in mouse and rat livers. , 1996, Chemical research in toxicology.

[37]  Qian Xiong,et al.  In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins. , 2009, Toxicon : official journal of the International Society on Toxinology.

[38]  U. Hofmann,et al.  Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1). , 2005, British journal of clinical pharmacology.

[39]  R. Kim,et al.  Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants , 2007, Pharmacogenetics and genomics.

[40]  Pingping Shen,et al.  Identification of human liver mitochondrial aldehyde dehydrogenase as a potential target for microcystin-LR. , 2006, Toxicology.

[41]  S. Sekiya,et al.  Mutagenicity of microcystin-LR in human RSa cells. , 1998, International journal of molecular medicine.

[42]  P. Cohen,et al.  The cyanobacterial toxin microcystin binds covalently to cysteine‐273 on protein phosphatase 1 , 1995, FEBS letters.

[43]  K. Harada,et al.  Neoplastic nodular formation in mouse liver induced by repeated intraperitoneal injections of microcystin-LR. , 1997, Toxicon : official journal of the International Society on Toxinology.

[44]  G. Codd,et al.  Distribution of Microcystis aeruginosa peptide toxin and interactions with hepatic microsomes in mice. , 1987, Pharmacology & toxicology.

[45]  C. Ong,et al.  Microcystic cyanobacteria extract induces cytoskeletal disruption and intracellular glutathione alteration in hepatocytes. , 2000, Environmental health perspectives.

[46]  G. Serban,et al.  Cadherins Mediate Both the Association between PS1 and β-Catenin and the Effects of PS1 on β-Catenin Stability* , 2005, Journal of Biological Chemistry.

[47]  Y. Ueno,et al.  Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. , 1996, Carcinogenesis.

[48]  I. Maatouk,et al.  Genotoxic potential of Microcystin‐LR and nodularin in vitro in primary cultured rat hepatocytes and in vivo in rat liver , 2005, Environmental toxicology.

[49]  M. Wickstrom,et al.  Effects of microcystin-LR on actin and the actin-associated proteins alpha-actinin and talin in hepatocytes. , 1995, Natural toxins.

[50]  I. Falconer Cyanobacterial toxins of drinking water supplies : cylindrospermopsins and microcystins , 2005 .

[51]  Á. Jos,et al.  Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to microcystin-LR administered intraperitoneally. , 2005, Toxicon : official journal of the International Society on Toxinology.

[52]  Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[53]  A. Annila,et al.  Solution Structure of Nodularin , 1996, The Journal of Biological Chemistry.

[54]  W. Carmichael,et al.  Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR , 2005, Journal of Cancer Research and Clinical Oncology.

[55]  L. Tang,et al.  Toxic response indicators of microcystin-LR in F344 rats following a single-dose treatment. , 2008, Toxicon : official journal of the International Society on Toxinology.

[56]  C. McDermott,et al.  The cyanobacterial toxin, microcystin-LR, can induce apoptosis in a variety of cell types. , 1998, Toxicon : official journal of the International Society on Toxinology.

[57]  S. Yu,et al.  [The relationship between cyanotoxin (microcystin, MC) in pond-ditch water and primary liver cancer in China]. , 2001, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[58]  Jennifer A. Markovics The roles of the Rb and p53 tumor suppressor pathways in an intestinal tumorigenesis model system , 2006 .

[59]  Takayoshi Suzuki,et al.  Genotoxicity of microcystin-LR in human lymphoblastoid TK6 cells. , 2004, Mutation research.

[60]  R. Bhattacharya,et al.  The cyanobacterial toxin microcystin-LR induced DNA damage in mouse liver in vivo. , 1996, Toxicology.

[61]  Wei Zhang,et al.  Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide. , 2006, British journal of clinical pharmacology.

[62]  J. Eriksson,et al.  Toxins affecting cell signalling and alteration of cytoskeletal structure. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.

[63]  C. van Hoof,et al.  Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. , 2003, Biochimica et biophysica acta.

[64]  Supratim Choudhuri,et al.  Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[65]  K. Maximov,et al.  The Role of p53 Tumor-Suppressor Protein in Apoptosis and Cancerogenesis , 2008 .

[66]  G. Serban,et al.  Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stability. , 2005, The Journal of biological chemistry.

[67]  M. Filipič,et al.  Microcystin-LR induces oxidative DNA damage in human hepatoma cell line HepG2. , 2003, Toxicon : official journal of the International Society on Toxinology.

[68]  N. Berndt,et al.  Protein dephosphorylation and the intracellular control of the cell number. , 1999, Frontiers in bioscience : a journal and virtual library.

[69]  C. Ong,et al.  Pivotal role of mitochondrial Ca(2+) in microcystin-induced mitochondrial permeability transition in rat hepatocytes. , 2001, Biochemical and biophysical research communications.

[70]  K. Harada,et al.  Comparison of protein phosphatase inhibitory activity and apparent toxicity of microcystins and related compounds. , 2002, Toxicon : official journal of the International Society on Toxinology.

[71]  J. Fraumeni,et al.  International trends and patterns of primary liver cancer , 2001, International journal of cancer.

[72]  W. Carmichael,et al.  Naming of cyclic heptapeptide toxins of cyanobacteria (blue-green algae). , 1988, Toxicon : official journal of the International Society on Toxinology.

[73]  N. Abdel-Hamid Update to risk factors for hepatocellular carcinoma , 2009 .

[74]  Jamie Bartram,et al.  Toxic Cyanobacteria in Water: a Guide to Their Public Health Consequences, Monitoring and Management Chapter 2. Cyanobacteria in the Environment 2.1 Nature and Diversity 2.1.1 Systematics , 2022 .

[75]  P. Cohen The structure and regulation of protein phosphatases. , 1989, Annual review of biochemistry.

[76]  E. López-Bayghen,et al.  Cell Proliferation, Differentiation and Apoptosis , 2012 .

[77]  R. Guzman,et al.  Characterization of Sublethal Microcystin-LR Exposure in Mice , 2002, Veterinary pathology.

[78]  M. O’Connor-McCourt,et al.  Regulation of signal transduction pathways by peptide toxins , 1994 .

[79]  Li-hong Xu,et al.  Proteomic analysis of cellular response to microcystin in human amnion FL cells. , 2005, Journal of proteome research.

[80]  J. G. Pace,et al.  Association of microcystin-LR and its biotransformation product with a hepatic-cytosolic protein. , 1991, Journal of biochemical toxicology.

[81]  A. Leong,et al.  Epidemiology and carcinogenesis of hepatocellular carcinoma. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[82]  Myrtle A. Davis,et al.  Chronic Microcystin Exposure Induces Hepatocyte Proliferation with Increased Expression of Mitotic and Cyclin-associated Genes in P53-deficient Mice , 2008, Toxicologic pathology.

[83]  W. Carmichael,et al.  Cyanobacteria secondary metabolites--the cyanotoxins. , 1992, The Journal of applied bacteriology.

[84]  Li-hong Xu,et al.  Altered expression of p53, Bcl-2 and Bax induced by microcystin-LR in vivo and in vitro. , 2005, Toxicon : official journal of the International Society on Toxinology.

[85]  B. Hemmings,et al.  Differential Inhibition and Posttranslational Modification of Protein Phosphatase 1 and 2A in MCF7 Cells Treated with Calyculin-A, Okadaic Acid, and Tautomycin* , 1997, The Journal of Biological Chemistry.

[86]  H. Fujiki,et al.  Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. , 1993, Advances in cancer research.

[87]  Xin Cai,et al.  A specific PP2A regulatory subunit, B56γ, mediates DNA damage‐induced dephosphorylation of p53 at Thr55 , 2007, The EMBO journal.

[88]  M. Burch,et al.  Toxicity of the blue-green alga (cyanobacterium) Microcystis aeruginosa in drinking water to growing pigs, as an animal model for human injury and risk assessment , 1994 .

[89]  Shun-zhang Yu Primary prevention of hepatocellular carcinoma , 1995, Journal of gastroenterology and hepatology.

[90]  N. Berndt,et al.  Protein phosphatase inhibition and in vivo hepatotoxicity of microcystins. , 1993, The American journal of physiology.

[91]  Y. Liu,et al.  The role of ROS in microcystin-LR-induced hepatocyte apoptosis and liver injury in mice. , 2007, Toxicology.

[92]  E. Dias,et al.  Morphological and ultrastructural effects of microcystin-LR from Microcystis aeruginosa extract on a kidney cell line. , 2009, Toxicon : official journal of the International Society on Toxinology.

[93]  A. Humpage,et al.  Microcystin‐LR and liver tumor promotion: effects on cytokinesis, ploidy, and apoptosis in cultured hepatocytes , 1999 .

[94]  Pingping Shen,et al.  Involvement of JNK regulation in oxidative stress-mediated murine liver injury by microcystin-LR , 2008, Apoptosis.

[95]  F. Tashiro,et al.  Enhancement of glutathione S-transferase placental-form positive liver cell foci development by microcystin-LR in aflatoxin B1-initiated rats. , 1999, Carcinogenesis.

[96]  M. Filipič,et al.  Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis. , 2008, Toxicon : official journal of the International Society on Toxinology.

[97]  M. Mumby,et al.  Reversible Phosphorylation of Bcl2 following Interleukin 3 or Bryostatin 1 Is Mediated by Direct Interaction with Protein Phosphatase 2A* , 1998, The Journal of Biological Chemistry.

[98]  Toshinori Yoshida,et al.  Tumor Necrosis Factor-α Expression and Kupffer Cell Activation in Hepatotoxicity Caused by Microcystin-LR in Mice , 2001 .

[99]  D. Ragland,et al.  Protection Against Microcystin-LR-Induced Hepatotoxicity by Silymarin: Biochemistry, Histopathology, and Lethality , 1991, Pharmaceutical Research.

[100]  Chwan-Li Shen,et al.  Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[101]  S. Shenolikar,et al.  Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. , 2001, Blood.

[102]  Myrtle A. Davis,et al.  Hepatic Gene Expression Changes in Mice Associated with Prolonged Sublethal Microcystin Exposure , 2007, Toxicologic pathology.